Literature DB >> 6430599

Pyruvate dehydrogenase subcomplex with lipoamide dehydrogenase deficiency in a patient with lactic acidosis and branched chain ketoaciduria.

S Matuda, A Kitano, Y Sakaguchi, M Yoshino, T Saheki.   

Abstract

The overall and three component activities of pyruvate dehydrogenase complex were measured in the liver and muscle from a patient who died at 1.9 years with increased concentrations of serum lactate, alpha-ketoglutarate and branched chain amino acids. The component activities of both lipoate acetyltransferase and pyruvate dehydrogenase were similar to those of normal controls, but the overall pyruvate dehydrogenase complex activity was 11 to 30% of controls and lipoamide dehydrogenase activity was not detected. The overall activity was significantly increased by the addition of lipoamide dehydrogenase purified from human liver. Immunochemical studies carried out with antibody prepared against lipoamide dehydrogenase from rat liver, could detect no immunoreactive material in liver and muscle homogenates from the patient, suggesting that the deficiency of lipoamide dehydrogenase activity was due to the lack of enzyme protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430599     DOI: 10.1016/0009-8981(84)90151-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

Review 1.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

3.  A decrease in glycine cleavage activity in the liver of a patient with dihydrolipoyl dehydrogenase deficiency.

Authors:  M Yoshino; Y Koga; F Yamashita
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

4.  Deficiency of the pyruvate dehydrogenase component in pyruvate dehydrogenase complex-deficient human fibroblasts. Immunological identification.

Authors:  L Ho; C W Hu; S Packman; M S Patel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 5.  Disorders of the pyruvate dehydrogenase complex.

Authors:  D Stansbie; S J Wallace; C Marsac
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

6.  Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient.

Authors:  T C Liu; H Kim; C Arizmendi; A Kitano; M S Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Fatal lactic acidosis due to deficiency of E1 component of the pyruvate dehydrogenase complex.

Authors:  M A Birch-Machin; I M Shepherd; M Solomon; S J Yeaman; D Gardner-Medwin; H S Sherratt; J G Lindsay; A Aynsley-Green; D M Turnbull
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

8.  Three genes for enzymes of the pyruvate dehydrogenase complex map to human chromosomes 3, 7, and X.

Authors:  S Olson; B J Song; T L Huh; Y T Chi; R L Veech; O W McBride
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

9.  Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance.

Authors:  M Cristina Bianchi; Michela Tosetti; Roberta Battini; Maria L Manca; Michelangelo Mancuso; Giovanni Cioni; Raffaello Canapicchi; Gabriele Siciliano
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.